PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27137718-1	2015	Opicapone, a novel third-generation catechol-O-methyltransferase inhibitor for use as adjunctive therapy in levodopa-treated Parkinson"s disease patients, was investigated on cardiac repolarization in healthy adult volunteers.	opicapone	0-9	catechol-O-methyltransferase	Homo sapiens	36-64